Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy

Launched by WOMEN AND INFANTS HOSPITAL OF RHODE ISLAND · Nov 12, 2023

Keywords

ClinConnect Summary

This clinical trial is looking into ways to encourage non-birthing partners of pregnant patients to get the Tdap vaccine, which protects against tetanus, diphtheria, and whooping cough. The researchers want to see if providing information about the vaccine and offering it during prenatal visits can increase vaccination rates compared to standard care. They will compare two approaches: one that includes education only and another that includes both education and the chance to get vaccinated in the office.

To participate, individuals must be partners of pregnant patients receiving care at a specific clinic, be between 19 and 50 years old, and either not have received the Tdap vaccine or be unsure of their vaccination status in the last ten years. Participants will receive both verbal and written information about the vaccine at the time they join the study, and they may also have the option to get vaccinated right away. It's important to know that those with a latex allergy cannot participate, and the study is currently recruiting participants who are fluent in either English or Spanish.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Partners of pregnant patients who are receiving their prenatal care at the OGCC
• • 2. 19-50 years old: This age range was selected as 19 years is both the age at which adult Tdap vaccination is recommended by the CDC as well as the age for the State supplied adult Tdap and Influenza Vaccines. Fifty years old is the upper limit of "reproductively aged individuals, the target population for this study.
• • 3. Have not or are unsure if they have received the adult Tdap vaccine or booster in the last 10 years: In addition to the CDC recommendation for adult Tdap vaccination and Td or Tdap booster every 10 years, the CDC recommends vaccination for any adult who is unsure of their vaccination status to ensure they are vaccinated as repeat vaccination does not cause additional harm.
• • 4. Fluency in English or Spanish: Consents, surveys, and Tdap and cocooning information will be available in both languages.
• Exclusion Criteria:
• • 1. Latex allergy: Contraindication to the state supplied Tdap vaccine
• • 2. Lethal fetal anomaly diagnosed prior to enrollment to prevent undue distress with follow-up postpartum